Cathie Wood has purchased over 1 million shares of software stock GitLab over the last few weeks. Cathie Wood is the CEO and chief investment officer of Ark Invest. Over the last several years ...

Cathie Wood is the CEO and chief investment officer of Ark Invest. Over the last several ... in AI will be agentic" and "agentic AI is the foundation of GitLab Duo workflow." ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over ...

Ark Invest purchased shares of CRISPR Therapeutics AG for both its ARK Genomic Revolution ETF ARKG and Ark Innovation ETF ARKK. The ARKG ETF bought 43,467 shares, while the ARKK ETF acquired ...

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns.

ARKK, the flagship fund of Ark Invest, has removed 187,968 shares of Palantir Technologies throughout January 2022. PLTR continues to be ARKK's fifth-largest holding with a market value at $351.9 ...

Cathie Wood's ARK ETFs have made their daily trades for Tuesday, January 28th, 2025, with significant activity across various sectors, particularly in technology and biotech. The trades reflect a ...

Cathie Wood's ARK ETFs published their daily trades for Friday, January 31st, 2025, with a notable emphasis on the biotech sector. Leading the charge in purchases was CRISPR Therapeutics AG ...